Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro may slash the risk of a disorder affecting nearly 7million ...

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Ozempic may lower dementia and nicotine dependence risk in people with type 2 diabetes. ... Ozempic May Reduce Need for Insulin in New Type 1 Diabetes Patients Published on September 8, 2023.

THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. ... Ozempic may reduce dementia: Research by Eden Teshome - 07/12/24 1:23 PM ET.

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. The findings, however, cannot be applied to users who do not have diabetes. The study ...

An analysis of over 100,000 medical records found that Ozempic users had a far lower dementia risk than those that took other diabetes drugs.

New research suggests that the diabetes drug and popular weight loss treatment semaglutide, commonly known as Ozempic and Wegovy, is linked with a lower risk of dementia — possibly adding to the ...

A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...

When compared to three other diabetes drugs, Ozempic was found to reduce dementia rates by up to 48 per cent, providing the "first robust evidence" that the drug could promote brain health and ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests. Researchers found these medications show promise in ...